We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

89 hedge funds and large institutions have $75.1M invested in Applied Genetic Technologies Corporation in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

1% less funds holding

Funds holding: 9089 (-1)

31% less capital invested

Capital invested by funds: $108M → $75.1M (-$33.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $183K

Holders
89
Holders Change
-1
Holders Change %
-1.11%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
39
Reduced
24
Closed
9
Calls
Puts
$183K
Net Calls
-$183K
Net Calls Change
-$545K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$756K +$93.6K +11,979 +12%
SO
27
STRS Ohio
Ohio
$592K +$161K +20,600 +32%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$535K +$14.7K +1,883 +2%
GIP
29
Granite Investment Partners
California
$532K -$23.7K -3,032 -4%
IHM
30
Iguana Healthcare Management
New York
$518K +$586K +75,000 New
AG
31
Algert Global
California
$506K +$51.1K +6,540 +10%
NCCM
32
Nine Chapters Capital Management
New Jersey
$440K +$498K +63,700 New
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$438K +$183K +23,400 +58%
CAM
34
ClariVest Asset Management
California
$418K +$187K +23,962 +65%
TC
35
TFS Capital
Pennsylvania
$414K +$282K +36,052 +150%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$400K +$22.2K +2,848 +5%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$392K +$137K +17,481 +45%
American Century Companies
38
American Century Companies
Missouri
$387K -$469K -59,980 -52%
Bank of America
39
Bank of America
North Carolina
$348K -$4.45K -570 -1%
Allianz Asset Management
40
Allianz Asset Management
Germany
$282K +$30.8K +3,945 +11%
DCM
41
Dupont Capital Management
Delaware
$252K
PCM
42
Prelude Capital Management
New York
$241K +$184K +23,500 +206%
PP
43
PDT Partners
New York
$228K +$79.7K +10,200 +45%
CS
44
Credit Suisse
Switzerland
$187K +$20.8K +2,662 +11%
Jacobs Levy Equity Management
45
Jacobs Levy Equity Management
New Jersey
$185K +$3.13K +400 +2%
FDCDDQ
46
Federation des caisses Desjardins du Quebec
Quebec, Canada
$181K +$205K +26,297 New
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$176K -$4.69K -600 -2%
TA
48
Teachers Advisors
New York
$157K
Invesco
49
Invesco
Georgia
$152K +$172K +21,990 New
Citadel Advisors
50
Citadel Advisors
Florida
$148K -$176K -22,590 -51%

AGTC Hedge Fund Activity: Q1 2017 in Review

89 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2017, worth a combined $75.1M — down 31% from $108M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new AGTC positions and 9 closed out — a net gain of 5 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $7.79M. The largest seller was Emerald Mutual Fund Advisers Trust, exiting entirely with an estimated $3.14M sold.

  • 89 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2017, down from 90 in Q4 2016.
  • Funds reported $75.1M of Applied Genetic Technologies Corporation stock for Q1 2017, down 31% quarter-over-quarter.
  • 14 funds opened new Applied Genetic Technologies Corporation positions in Q1 2017 and 9 closed out, a net change of +5 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2017 was BlackRock, an estimated $7.79M added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2017 was Emerald Mutual Fund Advisers Trust, an estimated $3.14M sold.

Based on aggregated 13F filings for Q1 2017.